Literature DB >> 4043568

Toxic products in hemorrhagic ascitic fluid generated during experimental acute hemorrhagic pancreatitis in dogs and a treatment which reduces their effect.

K Satake, I Koh, H Nishiwaki, K Umeyama.   

Abstract

Toxic substances produced in hemorrhagic ascitic fluid during experimental hemorrhagic pancreatitis in dogs were investigated. An average of 394 ml of ascitic fluid was produced within 5 h after the induction of acute pancreatitis by intraductal injection of a mixture of autologous bile and trypsin. Hemorrhagic ascitic fluid was collected under sterile conditions, which was confirmed by aerobic and anaerobic culture and a Limulus test. The sterile fluid was injected intraperitoneally into mice in doses of 2 and 3 ml, and the mortality rate 72 h after injection was 66.0 and 88.4%, respectively. It contained high concentrations of pancreatic enzymes, including trypsin and esterase activity, as well as bradykinin, histamine and prostaglandin. Autopsy and histological examination of mice revealed shock with lung damage. The results suggest that hemorrhagic ascitic fluid produced in pancreatitis may be an important factor for early deaths in acute pancreatitis. When a new synthetic antiprotease (nafamstat mesilate) in a dosage of 0.2 mg was mixed with 1 ml of ascitic fluid, trypsin was not detectable, and bradykinin was reduced 1.0 ng/ml from 8.0 ng/ml, while esterase activity decreased to one tenth of its previous activity. The mortality following injection of the solution decreased to 26.7 and 80.6%, respectively. These results indicate that peritoneal lavage with a solution containing antiprotease may be an effective treatment for hemorrhagic acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043568     DOI: 10.1159/000199225

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  6 in total

1.  Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitis.

Authors:  H Yamaguchi; H Weidenbach; H Lührs; M M Lerch; G Dickneite; G Adler
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

2.  Use of a synthetic protease inhibitor for the treatment of L-asparaginase-induced acute pancreatitis complicated by disseminated intravascular coagulation.

Authors:  M Murakawa; T Okamura; T Shibuya; M Harada; T Otsuka; Y Niho
Journal:  Ann Hematol       Date:  1992-05       Impact factor: 3.673

3.  Long peritoneal lavage decreases pancreatic sepsis in acute pancreatitis.

Authors:  J H Ranson; R S Berman
Journal:  Ann Surg       Date:  1990-06       Impact factor: 12.969

4.  Antecedent long term ethanol consumption in combination with different diets alters the severity of experimental acute pancreatitis in rats.

Authors:  O J Rämö
Journal:  Gut       Date:  1987-01       Impact factor: 23.059

5.  Effective peritoneal therapy of acute pancreatitis in the rat with glutaryl-trialanin-ethylamide: a novel inhibitor of pancreatic elastase.

Authors:  P Fric; J Slabý; E Kasafírek; P Kocna; J Marek
Journal:  Gut       Date:  1992-05       Impact factor: 23.059

6.  The effect of pancreatitis associated ascitic fluid on some functions of rat liver mitochondria. A possible mechanism of the damage to the liver in acute pancreatitis.

Authors:  J W Bielecki; J Dlugosz; E Pawlicka; A Gabryelewicz
Journal:  Int J Pancreatol       Date:  1989-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.